Search

everythinglearnresearchcommunity

for

Search:↓

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Androgen deprivation therapy for prostate cancer can cause sexual, physical, and psychological side effects, and doctors should manage these carefully.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Low-dose naltrexone may help reduce redness in certain scalp conditions.

ACTH-dependent Cushing's syndrome linked to metastatic cervical cancer is rare and has high risks.

A patient with Cronkhite-Canada Syndrome developed colon cancer that spread to the liver, showing the need for regular cancer checks in such patients.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

A woman with low thyroid function did not lose her hair during chemotherapy, possibly because her hair follicles were less affected by the treatment.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

Interleukin-2 treatment improved hair growth, sexual function, and reduced fungal infection in a patient with thymoma-related symptoms.

Norethisterone (jenapharm) therapy is effective for endometrial cancer.

A man's rare adrenal tumor caused feminization and white hair, was removed surgically, and improved after treatment.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

Doctors recommend postoperative radiation for male breast cancer, advise against testosterone for vasomotor symptoms post-adrenalectomy, suggest non-hormonal treatments for atrophic vaginitis after mastectomy, note no specific treatment for anticoagulant-induced hair loss, and call for more research on silicosis from silicon carbide exposure.

A 72-year-old man with sudden taste issues and hair growth was diagnosed with a severe stomach cancer and died within 5 months.

Healthcare claims databases can help monitor drug safety, but may report adverse events differently than direct surveillance.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

Certain hormone treatments can improve acne and related conditions in women.

Hormone therapy is safe and effective for transgender adults, but requires regular monitoring and mental health support.

Insulin resistance is linked to larger thyroid volume in patients with polycystic ovary syndrome.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

Hormone therapy for breast cancer often leads to sexual issues like vaginal dryness and decreased libido.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

The document explains the diagnosis and characteristics of woolly hair nevus and alopecia neoplastica.

A certain gene variant may increase the risk of polycystic ovary syndrome in Chinese women.

Thyroid hormones are important for skin health and changes in them can affect conditions like hair loss and eczema.